Patient Experience Management Platform NexHealth Raises $4 Million In Funding

By Dan Anderson • Sep 25, 2019
  • Patient Experience Management Platform company NexHealth announced it raised $4.2 million in funding led by Point Nine Capital

NexHealth — a Patient Experience Management Platform that is helping doctors modernize the patient experience — announced it raised $4.2 million in funding led by Point Nine Capital with participation from Rubicon Venture Capital, Scott Belsky, Josh Hannah, and existing investor iSeed Ventures.

“Our mission at NexHealth is to modernize the way people connect with their doctors all while empowering doctors to run thriving businesses. We work with some of the most progressive providers in the US and Canada and are looking forward to supporting even more providers with this new funding,” said Alamin Uddin, the co-founder and CEO at NexHealth.

Ever since NexHealth launched in 2017, the company has signed on thousands of doctors and is now supporting more than 4 million patients every month. With this funding round, NexHealth is opening an office in San Francisco and is planning to invest more into its product and continue product innovation.

“Alamin and his team at NexHealth have built one of the most innovative products in the market with some of the happiest customers in the industry. We’re excited to be partnering with the team at NexHealth,” added Christoph Janz, a founding Partner at Point Nine Capital.

As the Affordable Care Act catalyzed a number of changes in healthcare and dentists, the consumerization of healthcare is forcing doctors to change their business models. And patients are spending more out-of-pocking, shopping around for care, and have higher expectations from doctors.

On the other hand, doctors have been struggling with low reimbursements and increased competition. As patients are expecting more, doctors are aiming to meet the expectations. NexHealth helps doctors go direct to consumers and it provides a modern experience that patients have come to expect.